Nutrition Sensitive Interventions |
Hop and Khan 2002 (3) | Follow-up of national nutrition strategy 1995–2000 | 0–5 years | National | Child living in included area | National Plan of Action for Nutrition (NPAN), poverty reduction, infrastructure improvement, financial support, agriculture and aquaculture extension, health care, credit & education. | Weight and height | Stunting decreased from 58–37.3%. Underweight decreased from 51.5–25%. | Medium |
Mackintosh et al. 2002 (73) | Follow-up study to assess effectiveness of PANP (1993–1995) after 3 & 4 years (1998–1999) | 4–6 years (older) 1–3 years (younger group) | 55 | Families who previously participated in the PANP study and 1 younger child who had not received any PANP exposure Control group: no previous exposure to PANP | Poverty alleviation and nutrition program (PANP): growth monitoring and promotion, positive deviance inquiry, nutrition education and rehabilitation programme, and revolving loan program. (n = 46 household, 142 children) Control group: no intervention (n = 25 household) | Weight, height and WAZ | After 24 months: severe malnutrition (using WAZ) had reduced from 23–6%. No significant difference in the WAZ between the groups. Intervention group were ‘nutritionally better off’, had better feeding habits and weaning practices. | Medium |
Watanabe et al. 2005 (75) | Uncontrolled trial and follow up (2004) 5 years total | Intervention: 4–5 years Follow up: 6.5–8.5 years | 313 | Living in a commune with a high prevalence of malnutrition, poor socioeconomic conditions, no prior intervention programme, and leaders being interested in the project | Nutrition intervention group: including growth monitoring, nutrition education rehabilitation programme, nutrition-seeking and health-seeking behaviours, feeding children locally available nutritious foods, antenatal care, home gardening, savings & credit programme (n = 172). Nutrition programme (as above) & early childhood development (ECD) group: follow up to the prior intervention. Parental training: care and development. (n = 141) | Height, weight, HAZ, WAZ, WHZ, maternal and household characteristics | No statistically significant differences between intervention groups for anthropometric measures, or levels of stunting, wasting or underweight status. Longitudinal results: significant decrease in stunting prevalence in both the nutrition intervention group (13.4%, p < 0.01) and ECD & nutrition group (16.3%, p < 0.01). Severe stunting was only reduced in the ECD & nutrition group by 7.8% (p < 0.01). | Medium |
Pachon et al. 2002 (74) | Longitudinal, RCT 2 years | 5–25 months | 239 | Malnourished children matched with healthy children | Save the Children: positive deviance children interviewed to find key ‘good foods’ & behaviours. This included bimonthly nutrition rehabilitation for 9 months to identify ‘good foods,’ increase food quantity, and promote breastfeeding; and monthly growth monitoring and promotion sessions for 2 years (n = 119). Control group: no intervention (n = 119) | Weight, height, BMI, WAZ, HAZ, WHZ and breastfeeding status | At 12 months, intervention children consumed 20% more food than control group (p < 0.01), and were fed more times a day than the control group (p < 0.01) No statistically significant results for WAZ at 12 months. At months 2–6, for children < 15 months, 44.6% control group were undernourished compared to 68.8% (p < 0.05). However, children > 15 months, the intervention group (45.2%) had more well-nourished children than the control group (29.6%, p < 0.01). | Low |
Nutrition specific intervention studies |
Wieringa et al. 2007 (82) | Double blinded, RCT 6 months | 4–6 months | 784 | No chronic or severe illness, severe clinical malnutrition, anaemia, congenital anomalies | Supplementations for 7 days/week: Zinc (Zn): 10 mg/day (n = 196) Iron (Fe): 10 mg/day (n = 196) Iron + zinc: 10 mg each/day (n = 196) Control group: unfortified syrup (n = 196) | Weight, height, BMI, WAZ, HAZ, WHZ Hb, SF and serum zinc | The Fe and Fe + Zn groups had significantly higher levels of Hb and SF, and lower prevalence of anaemia, than the Zn and placebo groups (p < 0.0001). Iron supplementation significantly increases Hb levels (p < 0.0001). The Zn and Fe + Zn groups had significantly higher levels of zinc than the placebo and Fe groups (p < 0.0001). After baseline value adjustment, Zn levels were significantly higher in the Zn group compared to the Fe + Zn group (p = 0.02). Zinc supplementation had a negative effect on Hb concentrations, independent of iron supplementation (-2.5 g/L, p < 0.001, p-interaction = 0.25). | Low |
Hall et al. 2007 (77) | Cluster randomised trial (CRT), 17 months | 6 years | 1,080 | Children in primary schools who had taken part in a school feeding programme (fortified biscuits & milk) | Intervention group: fortified biscuits and milk, total 300kcal. Once a day, 5 times a week. Deworming. Nutrition and hygiene information (n = 360) Control group: no intervention (n = 720) | Weight, height, BMI, WHZ, WAZ and HAZ | The intervention group gained significantly more weight (3.19 kg vs 2.95 kg, p < 0.001) and height (8.15 cm vs 7.88 cm, p = 0.008) than the control group. After controlling for other limiting factors, the intervention programme was statistically significant for weight gain (p = 0.024), and the most undernourished children at baseline gained the least weight. | Low |
Hanieh et al. 2014 (81) | Cluster randomised trial (CRT) & follow up, 1 year | 6 months | 1,175 | Pregnant women | IFA: Iron + folic acid supplement daily (60 mg iron + 0.4 mg folic acid) (n = 395) IFA: Iron + folic acid supplement twice weekly (60 mg iron + 1.5 mg folic acid) (n = 399) MMN: Multiple micronutrient supplement + Iron and folic acid, twice weekly (60 mg iron + 1.5 mg folic acid + 13 other micronutrients) (n = 381) | Birthweight, length, and weight | No difference in birth weight as well as infant LAZ at 6 months of age in the twice weekly IFA group compared to the daily IFA group (MD 20.14, CI = 20.29 − 0.02), nor in the twice weekly MMN group compared to the daily IFA group (MD 20.04, CI = 20.20 − 0.11). | Low |
Hanieh et al. 2013 (90) | CRT and follow up 1 year | 6 months | Follow up: 891 | Pregnant women | IFA: Iron + folic acid supplement daily (n = 395) (60 mg iron + 0.4 mg folic acid) (n = 395) IFA: Iron + folic acid supplement twice weekly (n = 399) (60 mg iron + 1.5 mg folic acid) (n = 399) MMN: Multiple micronutrient supplement + Iron and folic acid, twice weekly (n = 381) (60 mg iron + 1.5 mg folic acid + 13 other micronutrients) (n = 381) | LAZ, head circumference, and HAZ | Follow up: Inverse association between maternal 25-OHD status and infant HAZ at 6 months (OR= -0.09, CI= -0.12 to -0.02) | Low |
Hop and Berger 2005 (78) | Double blinded, RCT 6 months | 6–12 months | 306 | Not severely wasted, not born prematurely | DDM: daily multiple micronutrient supplement (15 micronutrients including iron) (n = 76) WMM: weekly multiple micronutrient supplement (15 micronutrients including iron) (n = 77) DI: daily iron supplement (Daily adequate intake) (n = 75) Control group (P): daily placebo (n = 73) | Weight, length, LAZ, WAZ, plasma Hb, ferritin, zinc, riboflavin, retinol, tocopherol, and homocysteine | LAZ and WAZ worsened significantly in all groups, apart from LAZ in the DDM group which was significantly less than in the P and WMM groups (p = 0.001). Hb levels increased significantly more in the DMM group (mean = 16.4 g/L, CI = 12.4–20.4) than the P group (mean = 8.6 g/L, CI = 5.0-12.2). PF levels increased significantly more in the DMM and DI groups than the P and WMM groups. | Low |
Huy et al. 2009 (79) | Non-random, non-controlled pragmatic trial 2 years | 0–2 years | 586 | Pregnant women | 1: Iron (60 mg) + folic acid supplement (400 µg) (n = 211) 2: Multiple-micronutrient supplement (n = 203) 3: Gender training – maternal care from the family and community during pregnancy, and multiple-micronutrient supplement (n = 172) All: nutrition education- encouraging more frequent eating during pregnancy | Baby birth weight (LBW < 2500 g) At 2 years: weight and height | Average birth weight was higher in the two groups receiving multiple-micronutrient supplements than the group receiving iron = folic acid (2: +166 g 3: +105 g) than those receiving iron + folic acid (p < 0.05). LBW prevalence was lower in groups 2 & 3 than in group 1 (4.0%, 5.8% and 10.6% respectively, p < 0.05). At 2 years: children were taller in groups 2 & 3 than group 1 (p < 0.05) and stunting rates were ~ 10% lower (p < 0.05). No statistical significance for weight indicators. | Medium |
Le Huong et al. 2007 (83) | RCT 6 months | 6–8 years | 425 | Anaemic children | Iron fortified noodles, 10.7 mg/day (n = 86) Iron fortified noodles (10.7 mg/day) + mebendazole (n = 79) Mebendazole (deworming drug) (n = 79) Iron tablet (dose not reported) + mebendazole (n = 83) Control group: Placebo (n = 82) | Iron status: Hb, SF, sTfR, and haemoglobinopathies analysis. Inflammation: C-reactive protein. Parasite infection status and immunoglobulin E (IgE). | Hb concentration improved, and anaemia prevalence reduced in all groups (p < 0.001). Iron fortification significantly increased levels of Hb, SF and body iron (p = 0.037, p < 0.001 and p < 0.01, respectively), compared to just deworming and the placebo. Deworming showed no increased effect on Hb, iron status or IgE level compared to iron fortification | Low |
Thi Le et al. 2006 (91) | RCT 6 months | 6–8 years | 425 | Anaemic children | Iron fortified noodles, 10.7 mg/day (n = 86) Iron fortified noodles (10.7 mg/day) + mebendazole (n = 79) Mebendazole (deworming drug) (n = 79) Iron tablet (dose not reported) + mebendazole (n = 83) Control group: Placebo (n = 82) | Hb, SF, sTfR, and haemoglobinopathies analysis, CRP, parasite infection status, and immunoglobulin E (IgE). | Iron supplementation was more efficient than fortification to treat anaemia for all iron markers: Supplementation (Hb 6.19 g/L, p = 0.001; SF 117.3 µg/L, p = 0.001; and body iron 4.37 mg/kg, p = 0.001) compared to fortification (Hb 2.59 g/L, p = 0.07; SF 23.5 µg/L, p = 0.006; and body iron 1.37 mg/kg, p = 0.001) | Low |
Ninh et al. 1996 (86) | Double blinded, RCT 5 months | 4–36 months | 146 | Growth-retarded children, paired to healthy children | Zinc supplementation (10 mg) daily (n = 73) Control group: Placebo (n = 73) | Weight, height, WAZ, HAZ plasma circulating insulin-like growth factor (IGF-I) | Zinc supplementation increased weight by 0.5 kg (± 0.1 kg, p < 0.001) and height by 1.5cm (± 0.2 cm, p < 0.001). | Low |
Pham et al. 2010 (92) | RCT 6-month intervention 18-month follow-up | 5 months | 426 | Singleton, breastfed infants Severe anaemia (Hb < 70 g/L). | FF: instant fortified flour, daily for 6 months containing 11 vitamins & 12 minerals (n = 157) FC: complementary fortified food, daily for 6 months containing 11 vitamins & 12 minerals (n = 135) Control group (C group): no intervention (n = 134) | Micronutrient status: Hb, PF sTfR, zinc, and retinol. | Iron deficiency and iron deficiency anaemia were lower in the FF (13.4% and 6.7%) and FC (15.2% and 3.8%) groups compared to the C group (57.5 and 37.5%, p < 0.0001) | Low |
Phu et al. 2012 (93) | RCT 6-month intervention 18-month follow-up | 5 months | 377 | Severe anaemia (Hb < 70 g/L). | FF: instant fortified flour, daily for 6 months containing 11 vitamins & 12 minerals (n = 135) FC: complementary fortified food, daily for 6 months containing 11 vitamins & 12 minerals (n = 114) Control group: no intervention (n = 128) | Micronutrient status: Hb, PF, sTfR, zinc, and retinol | Retinol & zinc concentrations didn’t differ significantly among groups. Zinc deficiency was significantly lower in the FF group (36.1%) than C group (52.9%, p = 0.04). | Low |
Thach et al. 2015 (80) | Cluster randomised trial (CRT) 9-month intervention 25-month follow-up | 6 months | 426 | Pregnant women | Daily iron-folic acid (IFA) (60 mg elemental iron and 0.4 mg folic acid) (n = 34 communes) Twice weekly IFA (60 mg elemental iron and 1.5 mg folic acid) (n = 35 communes) Twice weekly multiple-micronutrient, iron and folic acid (60 mg elemental iron, 1.5 mg folic acid and MMN) (n = 35 communes) | Weight, length, LAZ and WAZ | The OR of anaemia was significantly lower among infants in the daily IFA (OR = 0.31, CI = 0.22–0.43), weekly IFA (0.38, CI = 0.26–0.54) and MMN (0.33, CI = 0.23–0.48) compared to groups in the observational study. | Low |
Berger et al. 2006 (94) | Double blinded, RCT 6 months | 4–7 months | 915 | Breastfed infants aged 4–7 months who free from chronic/ acute illness, severe malnutrition, or congenital abnormalities. | Fe-group: daily dose of 10 mg of iron as ferrous sulfate (n = 201) Zn-group: daily dose of 10 mg zinc as zinc sulfate (n = 195) Fe–Zn group: a daily dose of 10 mg iron þ 10 mg zinc (n = 190) Control group: Placebo: a dose of 100 000 IU of vitamin A was given to all infants to avoid VAD. (n = 198) | Stunting HAZ< -2 z-scores; wasting WHZ< -2 z-scores; underweight HAZ <-2 z-scores; anaemia = Hb < 110 g/l; low Fe stores = SF < 12 mg/l; low Zinc = Zinc < 9.9 mmol/l; IDA = simultaneous low SF and anaemia | Hb and SF levels significantly increased in both Fe and Fe + Zn groups (22.6 and 20.6 g/l for Hb; 36.0 and 24.8 mg/l for SF, respectively) compared to Zn and placebo groups (Hb: 6.4 and 9.8 g/l; SF: 18.2 and 16.9 mg/l, p < 0.0001). Zn increased more in Zn group (10.3 mmol/l) than in Fe + Zn group (8.0 mmol/l, p < 0.03), and Fe and placebo groups (1.6 and 1.2 mmol/l, p < 0.0001). Adding iron to zinc supplements negates the positive effect that sole zinc supplementation had on weight gain (WAZ) (p = 0.0004) and serum zinc (p = 0.02) showing a significant interaction between zinc and iron co-supplementation | Low |
Vuong et al. 2002 (88) | Controlled trial 30 days | 31–70 months | 185 | Children with low Hb concentration (100–120 g/L) | Vitamin A supplementation: using Momordica coincidences (gac) fruit (locally available) 1: fruit & rice = 3.5 mg β-carotene (n = 62) 2: powder & rice = 5.0 mg synthetic β-carotene (n = 60) 3: Plain rice, no fortification (n = 63) | Weight, height, HAZ, WAZ and plasma β-carotene and Hb concentration | β-carotene concentrations significantly higher in groups 1 & 2 than group 3 (p < 0.0001). Plasma retinol concentration significantly higher in group 1 (p = 0.0053) than group 2 and (p = 0.0053) group 3. Plasma retinol concentrations were significantly higher in group 1 than group 2 (p = 0.0053) and group 3 (p = 0.006) Hb concentrations increased in all 3 groups. In anaemic children, Hb levels were significantly lower in group 3 than group 1 (p = 0.017), but not than group 2. | Medium |
Xuan et al. 2013 (76) | RCT 5 months | 18–36 months | 334 | Not breastfed, no congenital or chronic diseases, and not consuming prebiotics or probiotics. | Intervention group: GAU 1 + milk-isocaloric and isoprotic gum, containing synbiotics, and fortified with vitamins A, C and E, and minerals zinc and selenium, and docosahexaenoic acid (n = 150) Control group: Fortified gum of sufficient protein, carbohydrates, fats, vitamins, and minerals (n = 184) | Height and weight gain, anaemia, zinc, and vitamin A deficiencies | The growth parameters of the intervention group increased significantly more than the control group: Weight (+ 0.43, p < 0.01) Height (+ 1 cm, p < 0.01) and BMI Z-score (+ 0.015, p < 0.05). MNDs were reduced in both the intervention and control groups, more in the intervention groups, but non-statistically significant, anaemia by 14.9% (p = 0.63), vitamin A by 9.5% (p = 0.05) and zinc by 13.6% (p = 0.44) | Low |
Nguyen et al. 2021 (87) | Uncontrolled trial, 6 months | 6–14 years | 151 | Children from 5 schools in Can Tho with Vitamin D deficiency/ insufficiency/ low BMD | 6–9 years: daily 600 mg elemental calcium & 400 IU vitamin D3 10–14 years: daily 1350 mg elemental calcium & 460 IU vitamin D3 | BMD, bone turnover markers, vitamin D level, and PTH | Vitamin D concentration significantly improved (p < 0.001). Prevalence of low BMD significantly reduced by 56.29% (p < 0.05) | Low |
Smuts et al. 2005 (2) | Double blinded, RCT 6 months | 6–11 months | 1,134 | Residents in study location, not born prematurely or low birth weight, not severely wasted nor severely anaemic, no fever | WMM: weekly multiple micronutrient supplements (n = 283) DMM: daily multiple micronutrient supplement (n = 280) DI: daily iron supplement (n = 288) Control group (P): placebo (n = 283) | CRP, Pb, retinol, Hb, and riboflavin level | The DMM group had a significantly greater weight gain, growing at an average rate of 207 g/mo compared with 192 g/mo for the WMM group, and 186 g/mo for the DI and P groups. DMM had significantly greater reduction in anaemia (-44% vs -35.1% and − 29.9%), ID (-17.6% vs -13.7% and 9.3%) and VAD (-10.7% vs -4.3% and − 11.4%) compared to DI and P groups (p < 0.05). | |